EMORY UNIVERSITY Diversified Active

Location: Atlanta, GA

CIK: 0001377635 · Show all filings

Period: Q1 2019 (← Previous) (Next →)

Filing Date: May 9, 2019

Total Value: $142M (100.0% shares, 0.0% debt)

Holdings (45)

BRK/A BERKSHIRE HATHAWAY INC DEL 24.8%
Value $35.24M Shares 117 Est. Cost $230816.08 Unrealized +31.2%
JD JD COM INC 8.4%
Value $11.98M Shares 397,528 Est. Cost $39.72 Unrealized
ASND ASCENDIS PHARMA A S 2.7%
Value $3.823M Shares 32,477 Est. Cost $21.03 Unrealized
FOLD AMICUS THERAPEUTICS INC 2.0%
Value $2.84M Shares 208,854 Est. Cost $10.42 Unrealized +17.2%
AMARIN CORP PLC 2.0%
Value $2.804M Shares 135,058 Est. Cost $13.91 Unrealized
ORCHARD THERAPEUTICS PLC 2.0%
Value $2.796M Shares 156,401 Est. Cost $17.88 Unrealized
ZOGENIX INC 2.0%
Value $2.792M Shares 50,758 Est. Cost $23.79 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 1.9%
Value $2.754M Shares 102,586 Est. Cost $22.87 Unrealized +2.1%
SOLID BIOSCIENCES INC 1.9%
Value $2.75M Shares 298,887 Est. Cost $17.93 Unrealized
IFRX INFLARX NV 1.9%
Value $2.716M Shares 71,884 Est. Cost $27.20 Unrealized +37.0%
MYOVANT SCIENCES LTD 1.9%
Value $2.672M Shares 111,925 Est. Cost $15.00 Unrealized
RA PHARMACEUTICALS INC 1.9%
Value $2.665M Shares 118,959 Est. Cost $18.20 Unrealized
RETROPHIN INC 1.8%
Value $2.503M Shares 110,627 Est. Cost $27.75 Unrealized
NBIX NEUROCRINE BIOSCIENCES INC 1.8%
Value $2.492M Shares 28,287 Est. Cost $60.96 Unrealized +37.1%
ALEXION PHARMACEUTICALS INC 1.8%
Value $2.491M Shares 18,429 Est. Cost $134.42 Unrealized
WVE WAVE LIFE SCIENCES LTD 1.7%
Value $2.464M Shares 63,434 Est. Cost $33.97 Unrealized +19.5%
INCY INCYTE CORP 1.7%
Value $2.453M Shares 28,518 Est. Cost $87.45 Unrealized -7.0%
SEATTLE GENETICS INC 1.7%
Value $2.444M Shares 33,368 Est. Cost $49.37 Unrealized
SYNTHORX INC 1.7%
Value $2.439M Shares 119,735 Est. Cost $20.37 Unrealized
GLOBAL BLOOD THERAPEUTICS IN 1.7%
Value $2.423M Shares 45,771 Est. Cost $33.00 Unrealized
ONC BEIGENE LTD 1.7%
Value $2.381M Shares 18,039 Est. Cost $62.64 Unrealized
ARGX ARGENX SE 1.7%
Value $2.349M Shares 18,819 Est. Cost $124.82 Unrealized
ATHENEX INC 1.6%
Value $2.312M Shares 188,696 Est. Cost $12.25 Unrealized
BMRN BIOMARIN PHARMACEUTICAL INC 1.6%
Value $2.254M Shares 25,376 Est. Cost $92.48 Unrealized +0.2%
MDGL MADRIGAL PHARMACEUTICALS INC 1.6%
Value $2.209M Shares 17,632 Est. Cost $215.87 Unrealized -42.4%
CRNX CRINETICS PHARMACEUTICALS IN 1.6%
Value $2.209M Shares 97,035 Est. Cost $27.74 Unrealized -11.4%
IOVA IOVANCE BIOTHERAPEUTICS INC 1.5%
Value $2.196M Shares 230,892 Est. Cost $13.36 Unrealized -27.3%
RYTM RHYTHM PHARMACEUTICALS INC 1.5%
Value $2.176M Shares 79,398 Est. Cost $27.64 Unrealized +4.0%
BCRX BIOCRYST PHARMACEUTICALS 1.5%
Value $2.157M Shares 265,013 Est. Cost $7.78 Unrealized +10.1%
ARENA PHARMACEUTICALS INC 1.5%
Value $2.142M Shares 47,779 Est. Cost $44.83 Unrealized
HRTX HERON THERAPEUTICS INC 1.5%
Value $2.113M Shares 86,477 Est. Cost $30.97 Unrealized -15.5%
SEAGATE TECHNOLOGY PLC 1.4%
Value $2.022M Shares 42,219 Est. Cost $37.49 Unrealized
GENOMIC HEALTH INC 1.4%
Value $2.005M Shares 28,619 Est. Cost $30.22 Unrealized
BFH ALLIANCE DATA SYSTEMS CORP 1.4%
Value $1.95M Shares 11,142 Est. Cost $147.64 Unrealized -18.5%
MS MORGAN STANLEY 1.4%
Value $1.94M Shares 45,964 Est. Cost $31.60 Unrealized +7.6%
KKR KKR & CO INC 1.4%
Value $1.927M Shares 82,041 Est. Cost $24.41 Unrealized -13.7%
CBRE CBRE GROUP INC 1.3%
Value $1.907M Shares 38,566 Est. Cost $30.58 Unrealized +53.5%
ACA ARCOSA INC 1.3%
Value $1.874M Shares 61,342 Est. Cost $29.80 Unrealized 0.0%
BHC BAUSCH HEALTH COS INC 1.3%
Value $1.873M Shares 75,828 Est. Cost $23.79 Unrealized +0.4%
C CITIGROUP INC 1.3%
Value $1.868M Shares 30,027 Est. Cost $52.94 Unrealized -7.9%
SLM SLM CORP 1.2%
Value $1.685M Shares 170,029 Est. Cost $11.57 Unrealized -10.6%
TRN TRINITY INDS INC 1.2%
Value $1.646M Shares 75,769 Est. Cost $16.28 Unrealized +7.7%
SUMMIT MIDSTREAM PARTNERS LP 0.6%
Value $852K Shares 87,560 Est. Cost $25.15 Unrealized
COCRYSTAL PHARMA INC 0.3%
Value $417K Shares 152,916 Est. Cost $5.95 Unrealized
SPY SPDR S&P 500 ETF TR 0.2%
Value $266K Shares 942 Est. Cost $267.76 Unrealized